The Vanguard Group's Stake in Spire Healthcare Group Disclosed

The Vanguard Group, Inc. has revealed its position concerning Spire Healthcare Group plc in compliance with Rule 8.3 of the Takeover Code. The disclosure details Vanguard's interest of 3.60% in Spire's ordinary shares, amounting to 14,516,251 securities. The information is based on the position held as of 19 February 2026.

The disclosure indicates no dealings in cash-settled derivatives or stock-settled derivatives associated with Spire. Additionally, The Vanguard Group confirmed no indemnity, option arrangements, or agreements affecting Spire's securities beyond disclosed holdings.

There are no connected disclosures for other parties in the offer nor any new security subscription rights. The Vanguard Group's declaration follows regulatory requirements, without supplementary open positions.